Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy : a multicentre, parallel, randomised, controlled, phase 3 trial
Citation
Turner , S , Cotton , S , Wood , J , Bell , V , Raja , E A , Scott , N , Morgan , H , Lawrie , L , Emele , D , Kennedy , C , Scotland , G , Fielding , S , MacLennan , G , Norrie , J , Forrest , M , Gaillard , E A , de Jongste , J C , Pijnenburg , M W , Thomas , M & Price , D 2022 , ' Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy : a multicentre, parallel, randomised, controlled, phase 3 trial ' , The Lancet. Respiratory medicine , vol. 10 , no. 6 , pp. 584-592 . https://doi.org/10.1016/S2213-2600(21)00486-0